Aceragen, Inc. financial data

Location
505 Eagleview Boulevard, Suite 212, Exton, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
IDERA PHARMACEUTICALS, INC. (to 1/13/2023), HYBRIDON INC (to 9/2/2005)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 125 % -82.5%
Debt-to-equity 232 % +1197%
Return On Equity -215 % -211%
Return On Assets -53 % +9.74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.42M shares -84.1%
Common Stock, Shares, Outstanding 8.35M shares -84.2%
Entity Public Float 24M USD -62.4%
Common Stock, Value, Issued 8K USD -84.9%
Weighted Average Number of Shares Outstanding, Basic 7.45M shares +139%
Weighted Average Number of Shares Outstanding, Diluted 7.45M shares +139%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.4M USD +36.4%
General and Administrative Expense 14.7M USD +59.9%
Operating Income (Loss) -44.2M USD -103%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22.1M USD -430%
Income Tax Expense (Benefit) -6.59M USD -205%
Net Income (Loss) Attributable to Parent -41M USD -88.1%
Earnings Per Share, Basic -8.78 USD/shares -130%
Earnings Per Share, Diluted -8.78 USD/shares +20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.12M USD -92.4%
Cash, Cash Equivalents, and Short-term Investments 2.1M USD -92.5%
Accounts Receivable, after Allowance for Credit Loss, Current 2.2M USD
Assets, Current 5.64M USD -80.8%
Property, Plant and Equipment, Net 4K USD -77.8%
Operating Lease, Right-of-Use Asset 471K USD -31%
Intangible Assets, Net (Excluding Goodwill) 67M USD
Goodwill 4.63M USD
Assets 78.5M USD +160%
Accounts Payable, Current 3.41M USD +1320%
Accrued Liabilities, Current 7.2M USD +115%
Liabilities, Current 17.9M USD +371%
Deferred Income Tax Liabilities, Net 3.01M USD
Operating Lease, Liability, Noncurrent 271K USD -45.1%
Other Liabilities, Noncurrent 22K USD
Liabilities 55.9M USD +1204%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23K USD
Retained Earnings (Accumulated Deficit) -781M USD -5.55%
Stockholders' Equity Attributable to Parent 22.5M USD -12.8%
Liabilities and Equity 78.5M USD +160%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.85M USD -116%
Net Cash Provided by (Used in) Financing Activities -74K USD -563%
Common Stock, Shares Authorized 140M shares 0%
Common Stock, Shares, Issued 8.35M shares -84.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.93M USD -118%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD +66.7%
Deferred Tax Assets, Valuation Allowance 129M USD -3.4%
Deferred Tax Assets, Gross 141M USD +5.53%
Operating Lease, Liability 560K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.9M USD -423%
Lessee, Operating Lease, Liability, to be Paid 626K USD -25.5%
Property, Plant and Equipment, Gross 819K USD 0%
Operating Lease, Liability, Current 223K USD +4.21%
Lessee, Operating Lease, Liability, to be Paid, Year Two 240K USD -4%
Lessee, Operating Lease, Liability, to be Paid, Year One 285K USD +14.5%
Deferred Income Tax Expense (Benefit) -273K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 66K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 101K USD -57.9%
Deferred Tax Assets, Operating Loss Carryforwards 94.4M USD +4.2%
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 803M USD +4.94%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares